Your session is about to expire
← Back to Search
GLP-1 Agonists for Osteoporosis
Study Summary
This trial will help show if GLP-1 receptor agonists help improve bone strength in postmenopausal women with T2DM.
- Osteoporosis
- Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have used GLP-1 receptor agonists or DPP4 inhibitors in the past.You have type 1 diabetes.Your kidney function has been very low in the past 3 months.You have been diagnosed with secondary osteoporosis.You have had pancreatitis in the past.You have been treated with medications for osteoporosis in the past.You have a medical device in your spine.You have been diagnosed with type 2 diabetes.A woman who has gone through menopause.You are older than 55 years old.Your average blood sugar level (Hemoglobin A1c) is between 7% and 10% in the past 6 months.You or someone in your family has had medullary thyroid cancer.
- Group 1: GLP-1 cohort
- Group 2: Non GLP-1 cohort
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what degree are GLP-1 receptor agonists causing adverse effects in patients?
"Our team has assigned a score of 2 to GLP-1 receptor agonist in terms of safety, since the medication is currently being tested during Phase 2. This indicates that while there is evidence supporting its security profile, efficacy must still be established."
What is the current recruitment rate of participants for this experiment?
"Affirmative. According to clinicaltrials.gov, this trial is currently on the hunt for participants and was originally posted on November 9th 2021. The most recent update occured on August 19th 2022 and 48 patients are being recruited from just one location."
Is there currently an opportunity to enroll in this medical research?
"Affirmative, this clinical trial is currently searching for participants. It was first advertised on November 9th 2021 and the data was most recently updated on August 19th 2022."
Share this study with friends
Copy Link
Messenger